0001753926-20-000335.txt : 20201015 0001753926-20-000335.hdr.sgml : 20201015 20201015093824 ACCESSION NUMBER: 0001753926-20-000335 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20201015 DATE AS OF CHANGE: 20201015 EFFECTIVENESS DATE: 20201015 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aspargo Laboratories, Inc. CENTRAL INDEX KEY: 0001805092 IRS NUMBER: 843757833 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-361806 FILM NUMBER: 201240589 BUSINESS ADDRESS: STREET 1: 550 SYLVAN AVENUE, SUITE 102 CITY: ENGLEWOOD CLIFFS STATE: NJ ZIP: 07632 BUSINESS PHONE: 201-408-4831 MAIL ADDRESS: STREET 1: 550 SYLVAN AVENUE, SUITE 102 CITY: ENGLEWOOD CLIFFS STATE: NJ ZIP: 07632 D/A 1 primary_doc.xml X0708 D/A LIVE 0001805092 Aspargo Laboratories, Inc. 550 SYLVAN AVENUE, SUITE 102 ENGLEWOOD CLIFFS NJ NEW JERSEY 07632 201-408-4831 DELAWARE None None Corporation true 2019 Michael Demurjian 610 Hubbard Avenue Red Bank NJ NEW JERSEY 07701 Executive Officer Director Promoter Michael Rice 155 Walnut Street Englewood NJ NEW JERSEY 07631 Director Fred Biehl 75 Ersenhower Parkway Roseland NJ NEW JERSEY 07068 Director Pharmaceuticals No Revenues 06b true 0001753926-20-000030 2020-02-02 false true false 10000 Eagles Coast Capital 297477 None None 782 JOHNNIE DODDS BOULEVARD, SUITE H-3 MOUNT PLEASANT SC SOUTH CAROLINA 29464 NC NORTH CAROLINA SC SOUTH CAROLINA false Arq Advisors 289499 David Sukoff 4232120 57 DEFOREST AVENUE SUMMIT NJ NEW JERSEY 07901 NJ NEW JERSEY NY NEW YORK false 8500000 7900000 600000 false 290 16660 0 0 false Aspargo Laboratories, Inc. /s/ Michael Demurjian Michael Demurjian CEO 2020-10-15